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Long-term aerobic exercise maintains peak VO2, improves 
quality of life, and reduces hospitalisations and mortality  
in patients with heart failure
Synopsis
Summary of: Belardinelli R, et al (2012) 10-year exercise 
training in chronic heart failure. J Am Coll Cardiol 60: 
1521–1528. [Prepared by Nora Shields, CAP Editor.]
Question: Does aerobic exercise improve peak VO2, 
quality of life, all-cause mortality, and cardiovascular 
morbidity in patients with chronic heart failure with mild 
to moderate symptoms? Design: Randomised, controlled 
trial with blinded outcome assessment. Setting: Hospital 
and community settings in Italy. Participants: Patients 
with chronic heart failure who were clinically stable, had 
a left ventricular ejection fraction < 40%, and the ability 
to exercise. Haemodynamically signiﬁcant valvular heart 
disease, uncontrolled diabetes or hypertension, and renal 
insufﬁciency were exclusion criteria. One hundred and 
thirty-ﬁve patients enrolled in the study and 123 completed 
the protocol. Randomisation of 123 participants (78% male) 
allotted 63 to the exercise group and 60 to a usual care 
group. Interventions: Both groups received counselling on 
smoking cessation, stress reduction and diet. In addition, 
the intervention group participated in an exercise training 
program for 10 years. The program consisted of 3 × 1-hour 
sessions per week of aerobic exercise at 60% peak VO2 at a 
hospital for 2 months under the supervision of a cardiologist 
and an exercise therapist, and 2 supervised 1-hour sessions 
at 70% peak VO2 the rest of the year in a community setting. 
Patients were also encouraged to exercise at home at least 
once a week. Each exercise session included 40 minutes of 
aerobic activity (cycling and treadmill). The control group 
received usual care and were advised to continue their 
usual physical activities for no longer than 30 minutes each 
session. Outcome measures: The primary outcomes were 
functional capacity, measured by peak VO2 as a percentage 
of predicted maximum VO2, and quality of life over 10 years. Quality of life was measured using the 21-item Minnesota 
living with heart failure questionnaire (maximum score 
105 points). Secondary outcomes were hospitalisations 
and cardiac mortality. Results: At 10-years, the exercise 
group had maintained a higher peak VO2 as a percentage of 
predicted maximum VO2 compared with the control group (mean difference 13%, 95% CI 11 to 15). Quality of life was 
signiﬁcantly better in the exercise group than the control 
group at 12 months (by 15 points (95% CI 10 to 20) and 
this was sustained throughout the 10 year study period. The 
groups differed signiﬁcantly on the relative risk (hazard 
ratios) of hospital readmission (0.6, 95% CI 0.3 to 0.8) 
and cardiac death (0.6, 95% CI 0.3 to 0.8) in favour of the 
exercise training group. Conclusion: Moderate intensity 
supervised aerobic exercise for patients with chronic 
heart failure performed at least twice-weekly for 10 years 
maintains functional capacity at more than 60% predicted 
maximum VO2. It also offers a sustained improvement 
in quality of life and a reduction in hospitalisations and 
cardiac mortality.
[95% CIs calculated by the CAP Editor.]
Commentary
Chronic heart failure (CHF) is a major public health 
problem with high mortality rates, and the number of 
hospitalisations for CHF has tripled over the past 30 years 
(Fida and Pina 2012). CHF is also very costly; in the USA it 
is the most frequent diagnosis on 30 day readmissions at a 
cost exceeding 18 billion dollars (Fida and Pina 2012). Thus, 
interventions aimed at reducing morbidity and mortality in 
this population of patients are a high priority. The study 
by Belardinelli et al shows that exercise training may be a 
very effective intervention, improving functional capacity, 
quality of life, mortality, and re-hospitalisation rate over a 
10 year period.
A very striking result was the improvement in VO2 peak 
which was maintained above 16 ml/kg/min over the 10 year 
period. This level of cardiorespiratory ﬁtness is associated 
with improved survival in CHF patients (Myers et al 2002). 
Interestingly, ejection fraction also improved ﬁve years 
after initiation of the program. Thus, long term, supervised 
exercise training improved two important prognostic 
markers as well as mortality and morbidity. However, given 
the relatively small number of patients in the study, these 
outcome data need to be viewed with caution.
The practicality of these ﬁndings could be questioned. 
Clearly, a 10-year medically supervised cardiac rehabilitation 
program is not feasible or cost effective in most clinical 
settings. However, considering the relative safety of exercise 
training, professionally supervised group based exercise 
training programs conducted in a health club setting as 
applied in the Belardinelli et al study is a potential avenue that 
deserves further consideration. It should also be recognized 
that these ﬁndings apply only to CHF with reduced ejection 
fraction, and it is still unknown if exercise has a positive 
impact on CHF patients with normal ejection fraction. 
Finally, given the small number of women in the study, it is 
unclear if these ﬁndings apply equally to men and women.
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